Trinity College Dublin


Trinity College Dublin By using this website you consent to the use of cookies in accordance with the Trinity cookie policy. For more information on cookies see our cookie policy.

Profile Photo

Dr. Carsten Ehrhardt

Associate Professor (Pharmacy)
25/6/7 WESTLAND ROW


Dr. Carsten Ehrhardt is Associate Professor in Pharmaceutics and Pharmaceutical Technology in the School of Pharmacy and Pharmaceutical Sciences at Trinity College Dublin. He holds a degree in Pharmacy from Hamburg University (Germany), and a Ph.D. in Biopharmaceutics from Saarland University (Saarbrücken, Germany). In September 2003, Carsten was appointed Lecturer in Biopharmaceutics at Saarland University and in August 2004, he accepted an offer for his current position. Carsten holds positions as Adjunct Assistant Professor at the School of Pharmacy, University of Southern California (USA) and as Professeur Invité at the Faculty of Pharmacy, Université Claude Bernard Lyon 1 (France). He is the former Director of Research in the School of Pharmacy and Pharmaceutical Sciences, TCD (2008-2012). Carsten is the recipient of honours and awards from the German Pharmaceutical Society (DPhG), American Physiological Society (Respiratory Chapter) and the Galenus Foundation. Carsten's research is focused on transport mechanisms and cell physiology of alveolar and bronchial epithelial barriers and the development of advanced drug delivery systems for pulmonary targeting. He is (co-)author of 1 book, 45 articles in peer-reviewed journals, 12 invited review articles, 11 book chapters and 206 abstracts, and has been invited to give 70 presentations at research institutions, international conferences and workshops.
  AEROSOL   ALPHA1-ANTITRYPSIN DEFICIENCY   ALVEOLAR EPITHELIAL-CELLS   ALVEOLAR EPITHELIUM   Asthma, Cystic Fibrosis, obstructive airways, interstitial lung diseases, pulmonary fibrosis   BRONCHIAL EPITHELIUM   Biomedical sciences   Biopharmaceutical aspects of drug delivery systems   Cell and tissue development   Drug development and evaluation   IN VITRO MODEL   IN-VITRO CULTURE   INHALATION   In vitro testing, trial methods   LIPOSOMES   LUNG   Membrane transport, structure and dynamics   Physiological and physiochemical barriers to drug absorption   Physiology   Respiratory System
Details Date
Adjunct Assistant Professor, Department of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California, Los Angeles, CA February 2008 - present
Chair, Drug Delivery: Emerging Therapies Networking Group, International Society for Aerosols in Medicine 2011 - 2013
Chair, Imaging, Modeling, and Physiology of Aerosols in the Lung, International Society for Aerosols in Medicine 2013 - 2015
Professor Invité, Laboratoire de Pharmacie Galénique Industrielle, Faculté de Pharmacie, Université Claude Bernard Lyon 1, Lyon, France March 2010 - present
Language Skill Reading Skill Writing Skill Speaking
English Fluent Fluent Fluent
German Fluent Fluent Fluent
Italian Medium Basic Basic
Spanish Basic Basic Basic
Details Date From Date To
American Association of Pharmaceutical Scientists, AAPS 2002 Present
American Physiological Society, APS 2006 Present
Deutsche Pharmazeutische Gesellschaft, DPhG 2000 Present
Gesellschaft für Wehrmedizin und Wehrpharmazie, VdSO 1997 Present
International Society for Aerosols in Medicine, ISAM 2003 Present
JJ Salomon, C Ehrhardt, KI Hosoya, The verapamil transporter in human alveolar epithelial cells (A549) does not interact with β2-receptor agonists, Drug Metabolism and Pharmacokinetics, 29, (1), 2014, p101-104 , Journal Article, PUBLISHED  TARA - Full Text  DOI
J Swaminathan, OL Gobbo, F Tewes, AM Healy, C Ehrhardt, Liposomes for systemic delivery of salmon calcitonin (sCT) by oral inhalation, J Aerosol Med Pulm Drug Deliv, 27, (1), 2014, p1-11 , Journal Article, PUBLISHED
F Tewes, C Ehrhardt, AM Healy, Superparamagnetic iron oxide nanoparticles (SPIONs)-loaded Trojan microparticles for targeted aerosol delivery to the lung, Eur J Pharm Biopharm, 86, (1), 2014, p98-104 , Journal Article, PUBLISHED
C Ehrhardt, Why do we know so little about absorption pathways in the lung?, Inhalation, 8, (2), 2014, p27-28 , Journal Article, PUBLISHED
JJ Salomon, VE Muchitsch, JC Gausterer, E Schwagerus, H Huwer, N Daum, CM Lehr, C Ehrhardt, The cell line NCI-H441 is a useful in vitro model for transport studies of human distal lung epithelial barrier, Mol Pharm, 11, (3), 2014, p995-1006 , Journal Article, PUBLISHED
J Swaminathan, C Ehrhardt, Effect of lyophilisation on liposomal systems for the delivery of salmon calcitonin (sCT), J Liposome Res, 2014, Journal Article, IN_PRESS
JN Seheult, P O'Connell, I Sulaiman, KC Tee, T Bholah, E MacHale, S D'Arcy, MS Holmes, G Crispino-O'Connell, RB Reilly, D Bergin, E Reeves, C Ehrhardt, AM Healy, RW Costello, An acoustic method for monitoring aerosol delivery from a DiskusTM dry powder inhaler, Pharm Res, 31, (10), 2014, p2735-2747 , Journal Article, PUBLISHED
MS Holmes, JN Seheult, P O'Connell, S D'Arcy, C Ehrhardt, AM Healy, RW Costello, RB Reilly, An acoustic based method to detect and quantify the effect of exhalation into a dry powder inhaler, J Aerosol Med Pulm Drug Deliv, 2014, Journal Article, IN_PRESS
X Hu, FF Yang, LH Quan, CY Liu, XM Liu, C Ehrhardt, YH Liao, Pulmonary delivered polymeric micelles - pharmacokinetic evaluation and biodistribution studies, Eur J Pharm Biopharm, 2014, Journal Article, ACCEPTED
N Chadderton, A Palfi, S Millington-Ward, O Gobbo, N Overlack, M Carrigan, M O'Reilly, M Campbell, C Ehrhardt, U Wolfrum, P Humphries, PF Kenna, GJ Farrar, Intravitreal delivery of AAV-NDI1 provides functional benefit in a murine model of Leber hereditary optic neuropathy, Eur J Hum Genet, 21, (1), 2013, p62-68 , Journal Article, PUBLISHED  DOI
  

Page 1 of 9
C Ehrhardt, A probable association between the ergothioneine transporter, OCTN1 and COPD, 33rd West Coast Salt and Water Club Meeting, Avila Beach, CA, 08/03/2014, 2014, Invited Talk, PRESENTED
C Ehrhardt, In vitro models of human distal lung and their application in pulmonary drug disposition research, Graduate School of Health, University of Technology, Sydney, Sydney, NSW, Australia, 09/04/2014, 2014, Invited Talk, PRESENTED
C Ehrhardt, Drug Transport(ers) in the Lung: Challenges in Drug Development, Woolcock Institute of Medical Research, Sydney, NSW, Australia, 11/09/2014, 2014, Invited Talk, PRESENTED
C Ehrhardt, Anatomy and cell physiology of the human lungs, ISPE Turkey Affiliate Pulmonary Drug Delivery Workshop, Istanbul, Turkey, 09/05/2014, 2014, Invited Talk, PRESENTED
C Ehrhardt, Biopharmazie der Lunge - Spielen Arzneistofftransporter eine Rolle?, Institut für Pharmazeutische Technologie, Goethe-Universität, Frankfurt am Main, Germany, 04/06/2014, 2014, Invited Talk, PRESENTED
C Ehrhardt, Drug disposition in the lung - what we do know and what we don't, Department of Physiology & Developmental Biology, Brigham Young University, Provo, UT, 15/05/2014, 2014, Invited Talk, PRESENTED
C Ehrhardt, Spielen Arzneistofftransporter im Lungenepithel eine biopharmazeutische Rolle?, Institut für Pharmazeutische Technologie, Technische Universität Braunschweig, Braunschweig, Germany, 18/06/2014, 2014, Invited Talk, PRESENTED
C Ehrhardt, The many unknowns of pulmonary drug disposition, Institut für Pharmazie, Freie Universität Berlin, Berlin, Germany, 18/07/2014, 2014, Invited Talk, PRESENTED
C Ehrhardt, Transporter-Effekte bei der Arzneistoffabsorption in der Lunge, Abteilung Pharmazeutische Technologie, Ruprecht-Karls-Universität, Heidelberg, Germany, 22/07/2014, 2014, Invited Talk, PRESENTED
C Ehrhardt, Wo geht's lang? Wege der Arzneistoffabsorption in der Lunge, Institut für Pharmazeutische Technologie und Biopharmazie, Philipps-Universität, Marburg, Germany, 02/09/2014, 2014, Invited Talk, PRESENTED

  

Page 1 of 9
Award Date
"Förderung der wissenschaftlichen Nachwuchses" Fellowship from the DPhG 2002
Fellowship, Trinity College Dublin 2013
Galenus Support Award 2007, Galenus Privatstiftung 2007
Galenus Support Award 2008, Galenus Privatstiftung 2008
Galenus Support Award 2009, Galenus Privatstiftung 2009
Galenus Support Award 2010, Galenus Privatstiftung 2010
Galenus Support Award 2011, Galenus Privatstiftung 2011
Galenus Support Award 2012, Galenus Privatstiftung 2012
International Research Collaboration Award, University of Sydney 2013
Poster Award at the 8th German Seminar on Aerosol Therapy, Marburg, Germany 2003
Recognition Award for Meritorious Research by a Young Investigator, American Physiological Society 2003
Travel grant from the CRS to attend the 30th Annual Meeting of the CRS, Glasgow, UK 2003
Travel grant from the DFG to attend the Experimental Biology Meeting, Washington, DC, USA 2004
Travel grant from the DPhG to attend the 6th European Congress of Pharmaceutical Sciences - EUFEPS 2000, Budapest, Hungary 2000
Travel grant from the Nagai Foundation to attend the 28th Annual Meeting of the CRS, San Diego, CA, USA 2001
I have established an international reputation in my field of expertise, "Inhalation Drug Delivery and Pulmonary Biopharmaceutics". The aim of this field of scientific endeavour is to describe the behaviour of drug and biological molecules following their administration to the lung as inhaled aerosols. The field has become increasingly important over the last 20 years as the incidence of lung-related diseases and the morbidity due to these conditions is increasing a more than 5% per year. My research is primarily preclinical using both cell and animal models, which allows a wide array of discovery and development works. The technical expertise of my laboratory ranges from pharmaceutics to pharmacokinetics, pharmacology, physiology, cell & molecular biology to pathology and immunocytochemistry. Recently, we started multidisciplinary, translational investigations into the role that drug transporters play in the pathogenesis of tobacco-related chronic obstructive pulmonary disease (COPD). Previously, we have been successfully developing the following research projects: - Lung cellular disposition of inhaled beta-2 agonists for asthma therapy - Investigation of drug transporter expression in proximal and distal lung - Characterisation of delta-ENaC expression and function in airway epithelia - Determination of the role of OCTN1 in tobacco smoke-related COPD - Novel lipid-based drug delivery systems for pulmonary delivery of sCT I am an internationally recognised leader in the field of in vitro models of respiratory epithelial barriers and my laboratory has been credited with pioneering work on the development of primary cultures of human alveolar epithelial cells. The unique combination of cell physiological basis and pharmaceutical application has lead to numerous research collaborations, nationally and internationally, as well as to a continuous stream of visitors to my laboratory. I am PI of TBSI and an SFI Strategic Research Cluster - the Irish Drug Delivery Network (commenced December 2007), which brings together expertise from several leading academic institutions (UCD, UCC, RCSI and TCD) and a number of Irish drug delivery companies.